What was Suvanza’s price range in the past 12 months?
Suvanza lowest stock price was $0.05 and its highest was $0.05 in the past 12 months.
What is Suvanza’s market cap?
Suvanza’s market cap is $2,652.
When is Suvanza’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Suvanza overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Suvanza pay dividends?
Suvanza does not currently pay dividends.
What is Suvanza’s EPS estimate?
Suvanza’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Suvanza have?
Suvanza has 13,259,332 shares outstanding.
Which hedge fund is a major shareholder of Suvanza?
Currently, no hedge funds are holding shares in SUVZ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Suvanza
Suvanza Pharma, LLC is an emerging biotechnology enterprise dedicated to developing RapiDerm, an innovative drug delivery system applied to the skin, specifically targeting dermatological disorders. The company, which began operations in 2004 and is headquartered in Miami Beach, Florida, officially changed its name from Hamilton PNG to Suvanza Pharma, LLC in March 2010.